Literature DB >> 2226508

Factors predicting mortality in idiopathic dilated cardiomyopathy.

M Komajda1, J P Jais, F Reeves, B Goldfarb, J B Bouhour, Y Juillieres, J Lanfranchi, P Peycelon, P Geslin, D Carrie.   

Abstract

A study of factors predicting mortality was performed in 201 patients with dilated cardiomyopathy (163 men, 38 women, mean age: 48 +/- 11 years) by multivariate analysis (Cox Model) of 51 clinical, electrocardiographic, echocardiographic and haemodynamic parameters, 56 patients died during follow-up (mean follow-up: 57.1 +/- 29.9 months). 5 year survival was 77 +/- 3%. The following parameters were independent predictors of mortality: first symptom: pulmonary oedema, peripheral oedema, syncope; duration of symptoms at the time of inclusion; end systolic left ventricular volume; end diastolic left ventricular diameter; pulmonary artery systolic pressure; and their combination had the most accurate predictive value for death. A quantitative score (s) was calculated and used to define three subgroups: A:s less than or equal to 4.5; B: 4.5 less than s less than 6; C:s greater than or equal to 6. Five-year survival was 90 +/- 5% in group A; 84 +/- 4% in B and only 53 +/- 7% in C. In conclusion, overall survival was good in this population of all stage dilated cardiomyopathy; factors related to clinical severity, left ventricular dilation, systolic pulmonary artery pressure and duration of symptoms defined a subgroup of patients with poor prognosis.

Entities:  

Mesh:

Year:  1990        PMID: 2226508     DOI: 10.1093/oxfordjournals.eurheartj.a059803

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  16 in total

1.  Comparison of gated single-photon emission computed tomography with magnetic resonance imaging for evaluation of left ventricular volumes and ejection fraction in patients with idiopathic dilated cardiomyopathy.

Authors:  Petri Sipola; Keijo Peuhkurinen; Esko Vanninen
Journal:  Int J Cardiovasc Imaging       Date:  2010-09-28       Impact factor: 2.357

Review 2.  Right heart catheterization and risk stratification in advanced heart failure.

Authors:  Michael Craig; Naveen L Pereira
Journal:  Curr Heart Fail Rep       Date:  2006-09

3.  Measurement of left ventricular volumes and function with O-15-labeled carbon monoxide gated positron emission tomography: comparison with magnetic resonance imaging.

Authors:  Hadassa A Hofman; Paul Knaapen; Ronald Boellaard; Olga Bondarenko; Marco J W Götte; Willem G van Dockum; Cees A Visser; Albert C van Rossum; Adriaan A Lammertsma; Frans C Visser
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

4.  Impact of atrial fibrillation on outcome of patients with idiopathic dilated cardiomyopathy: data from the Heart Muscle Disease Registry of Trieste.

Authors:  Aneta Aleksova; Marco Merlo; Massimo Zecchin; Gastone Sabbadini; Giulia Barbati; Giancarlo Vitrella; Andrea Di Lenarda; Gianfranco Sinagra
Journal:  Clin Med Res       Date:  2010-08-03

5.  What explains black-white differences in survival in idiopathic dilated cardiomyopathy? The Washington, DC, Dilated Cardiomyopathy Study.

Authors:  S S Coughlin; L Myers; R K Michaels
Journal:  J Natl Med Assoc       Date:  1997-04       Impact factor: 1.798

6.  N-terminal pro-B-type natriuretic peptide and long-term mortality in non-ischaemic cardiomyopathy.

Authors:  Florian Krackhardt; Hans-Dirk Düngen; Tobias Daniel Trippel; Simone Inkrot; Verena Tscholl; Peter Schlattmann; Kathrin Kehrt; Wilhelm Haverkamp
Journal:  Wien Klin Wochenschr       Date:  2011-11-23       Impact factor: 1.704

7.  Black-white differences in mortality in idiopathic dilated cardiomyopathy: the Washington, DC, dilated cardiomyopathy study.

Authors:  S S Coughlin; J S Gottdiener; K L Baughman; A Wasserman; E S Marx; M C Tefft; B J Gersh
Journal:  J Natl Med Assoc       Date:  1994-08       Impact factor: 1.798

Review 8.  How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death?

Authors:  J G Cleland; S Puri
Journal:  Br Heart J       Date:  1994-09

9.  Determinants of extracellular matrix remodelling are differentially expressed in paediatric and adult dilated cardiomyopathy.

Authors:  Tain-Yen Hsia; Jeremy M Ringewald; Robert E Stroud; Geoffrey A Forbus; Scott M Bradley; Wendy K Chung; Francis G Spinale
Journal:  Eur J Heart Fail       Date:  2010-12-08       Impact factor: 15.534

10.  Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

Authors:  A Di Lenarda; G Secoli; A Perkan; D Gregori; G Lardieri; B Pinamonti; G Sinagra; M Zecchin; F Camerini
Journal:  Br Heart J       Date:  1994-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.